GlobeNewswire Inc | May 27, 2021 07:00AM EDT

May 27, 2021

GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.

Details on the Jefferies fireside chat presentation are as follows:

Title: 2021 Jefferies Virtual Healthcare Conference Presenters: Vipin Garg, Ph.D., Chief Executive Officer Scot Roberts, Ph.D., Chief Scientific Officer Scott Harris, M.D., Chief Medical Officer Date/Time: Wednesday, June 2, 2021 at 11:30 am ET

A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). For more information on Altimmune, please visitwww.altimmune.com.

Investor & Media Contacts: Will Brown Stacey JurchisonChief Financial Officer Sr. Dir, Investor RelationsPhone: 240-654-1450 Phone: 410-474-8200wbrown@altimmune.com sjurchison@altimmune.com